<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An analysis was made of clinical complications, determined with objective methods, in 68 patients at the University Clinic of Navarra with the clinical suspicion of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and presence of anticardiolipin antibodies (ACA) </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with IgG higher than 23 GPL were considered for the study </plain></SENT>
<SENT sid="2" pm="."><plain>The most prevalent pathology was <z:mp ids='MP_0005048'>thrombosis</z:mp>: <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (42.6%) and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> (22%) </plain></SENT>
<SENT sid="3" pm="."><plain>Other complications were abortions (23.8% of the 42 women) and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (12.1%) </plain></SENT>
<SENT sid="4" pm="."><plain>With respect to the localisation of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, predominance corresponded to lower extremities (51.7%), followed by <z:hpo ids='HP_0002638'>superficial thrombophlebitis</z:hpo> (27.5%) and pulmonary <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (20.6%) </plain></SENT>
<SENT sid="5" pm="."><plain>Among the arterial complications, the most frequent were cerebrovascular disease (86.6 %) and <z:hpo ids='HP_0001677'>coronary disease</z:hpo> (13.4%) </plain></SENT>
<SENT sid="6" pm="."><plain>There was no correlation between the presence of high values of ACA and the prevalence or severity of clinical manifestations </plain></SENT>
<SENT sid="7" pm="."><plain>In the series of patients with ACA IgG&gt;23 GPL, we appreciated a high percentage of venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> detected with objective methods </plain></SENT>
<SENT sid="8" pm="."><plain>The presence of ACA constitutes a prothrombotic risk factor </plain></SENT>
</text></document>